http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9900149-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0973b70303a6689b2d3eca1118129321 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-223 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e41b429a928d617cf2116a1900130ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e85ff03dd0bede14713a89d5d4aa377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86bdfc8ea16834002758b66378e07778 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb9c64305b634d6ee0aa814f5ae5ff32 |
| publicationDate | 1999-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9900149-A1 |
| titleOfInvention | Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases |
| abstract | It has been discovered that microparticles formed from natural or synthetic polymer with thicker walls have significantly enhanced echogenicity as compared with microparticles having thinner walls. The effect of wall thickness has been determined experimentally as well as inserted into a formula for use in predicting the optimum conditions. In the preferred embodiment, the polymers are synthetic biodegradable polymers and the wall thickness is between about 100 and 660 nm, although wall thicknesses from about 20 nm to in excess to 500 nm can be used. The microparticles are manufactured with a diameter suitable for the targeted tissue to be imaged, for example, with a diameter for between 0.5 and 8 microns for intravascular administration, and a diameter of between 0.5 and 5 mm for oral administration for imaging of the gastrointestinal tract or other lumens. Preferred polymers are polyhydroxy acids such as polylactic acid-co-glycolic acid, polylactide or polyglycolide, most preferably conjugated to polyethylene glycol or other materials inhibiting uptake by the reticuloendothelial system (RES). The microspheres may be used in a variety of ultrasound imaging applications including cardiology applications, blood perfusion applications as well as for organ and peripheral vein imaging. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6776761-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0112069-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7314636-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7887599-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004320514-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004320514-B8 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005120587-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1609483-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1077162-C |
| priorityDate | 1997-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.